Australia's Island Pharmaceuticals hits 3-week high on US patent grant

Island Pharmaceuticals

13/09/2023 02:11

** Shares of Island Pharmaceuticals  ILA.AX  rise as much as
4.9% to A$0.085, their highest since Aug 21
    ** The biotechnology co says lead asset, ISLA-101, granted
key patent from the United States Patent and Trademark Office
(USPTO) covering methods of preventing or delaying the onset of
the symptoms of dengue fever
    ** Stock set for best day since Sept 6, if gains hold
    ** At least 82,500 shares change hands, compared with the
30-day average volume of 37,373
    ** Stock down 56.2% YTD, as of last close
    

 (Reporting by Adwitiya Srivastava in Bengaluru)
 ((Adwitiya.Srivastava@thomsonreuters.com;))